The clinical coordinator reported to a monitor that: patient visited a hospital in (b)(6), with cough on (b)(6) 2015.The patient got a chest x-ray test and was diagnosed with bronchial pneumonia and was required hospitalization.The pneumonia was getting better, but the patient remained in the hospital.Post the admission to the hospital, the patient was given the following medications: maxipime for injection 2g/day, codeine phosphate hydrate 3g/day, ambroxol hydrochloride 3 tablets/day.The product was not returned for investigation.
|
A bath record review of lot c129 was conducted.There were no nonconformances.The lot met all release requirements.Trends were reviewed for complaint category, cough, and no trends were detected.Based on the assessment, the (b)(6) male with cgvhd developed cough two days after the treatment.Chest xray was performed and bronchial pneumonia was diagnosed.Patient was hospitalized and given antibiotics.Patient's pneumonia is getting better.The health care professional does not think there is relationship between the cough and ecp.This case is serious and unrelated to ecp.This case is reportable due to the medical intervention.The assessment is based on information available at the time of the investigation.No product was returned for analysis; therefore, it could not be determine if this specific product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further action will be taken through the capa/ continuous improvement process.(b)(4).
|